Steven Cohen Ideaya Biosciences, Inc. Transaction History

Point72 Asset Management, L.P.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$13.49 - $18.72 $34,858 - $48,372	2,584 Added 96.38%	5,265 $72,000
Q4 2022 Feb 14, 2023	BUY	$14.47 - $18.17 $38,794 - $48,713	2,681 New	2,681 $48,000
Q2 2022 Aug 15, 2022	SELL	$8.28 - $13.88 $2.8 Million - $4.69 Million	-338,017 Reduced 18.3%	1,509,000 $20.8 Million
Q1 2022 May 16, 2022	BUY	$11.18 - $24.02 $5.55 Million - $11.9 Million	496,617 Added 36.78%	1,847,017 $20.7 Million
Q4 2021 Feb 14, 2022	BUY	$20.95 - $26.88 $7.69 Million - $9.87 Million	367,200 Added 37.35%	1,350,400 $31.9 Million
Q3 2021 Nov 15, 2021	BUY	$17.26 - $27.08 $5.06 Million - $7.94 Million	293,255 Added 42.5%	983,200 $25.1 Million
Q2 2021 Aug 16, 2021	SELL	$17.76 - $24.83 $2.55 Million - $3.57 Million	-143,755 Reduced 17.24%	689,945 $14.5 Million
Q1 2021 May 17, 2021	SELL	$13.48 - $23.77 $3.74 Million - $6.59 Million	-277,411 Reduced 24.97%	833,700 $19.6 Million
Q4 2020 Feb 16, 2021	SELL	$12.17 - $17.52 $554,380 - $798,088	-45,553 Reduced 3.94%	1,111,111 $15.6 Million
Q3 2020 Nov 16, 2020	BUY	$11.22 - $14.46 $1.65 Million - $2.13 Million	147,400 Added 14.6%	1,156,664 $14.5 Million
Q2 2020 Aug 14, 2020	BUY	$3.59 - $18.57 $2.91 Million - $15.1 Million	811,649 Added 410.72%	1,009,264 $14.3 Million
Q3 2019 Nov 15, 2019	BUY	$6.06 - $10.91 $12,410 - $22,343	2,048 Added 1.05%	197,615 $1.78 Million
Q2 2019 Aug 14, 2019	BUY	$9.58 - $11.95 $1.87 Million - $2.34 Million	195,567 New	195,567 $1.95 Million

213

80.8M

69K

20K

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $1.07B
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.